SYN023 clinical trials
Also written SYN023.
How each study uses SYN023 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- SYN023
- 4
Studies by the year they started
4 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Synermore Biologics Co., Ltd. (2) · Synermore Biologics (Suzhou) Co., Ltd. (2)
Often tested with
Tested in the same studies.
Rabies virus strain PM-1503-3M antigen (propiolactone inactivated) (1) · Rabies virus strain flury LEP antigen (propiolactone inactivated) (1)
Studies
Open first, then newest update. How each study uses SYN023 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of RabiesCompletedPhase 2Synermore Biologics Co., Ltd.NCT03961555Written as SYN023
- SYN023 With Rabies Vaccine in Healthy Pediatric SubjectsCompletedPhase 1Synermore Biologics (Suzhou) Co., Ltd.NCT07342257Written as SYN023
- A Phase III Clinical Study to Evaluate SYN023's Efficacy and SafetyCompletedPhase 3Synermore Biologics (Suzhou) Co., Ltd.NCT04644484Written as SYN023
- A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies VaccinesCompletedPhase 1/2Synermore Biologics Co., Ltd.NCT02956746Written as SYN023